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Abstract
Objective Certain pulmonary diseases are associated with
cardiovascular disease (CVD). Therefore we investigated the
incremental predictive value of pulmonary, mediastinal and
pleural features over cardiovascular imaging findings.
Methods A total of 10,410 patients underwent diagnostic
chest CT for non-cardiovascular indications. Using a case-
cohort approach, we visually graded CTs from the cases and
from an approximately 10 % random sample of the baseline
cohort (n=1,203) for cardiovascular, pulmonary, mediastinal
and pleural findings. The incremental value of pulmonary
disease-related CT findings above cardiovascular imaging
findings in cardiovascular event risk prediction was quantified
by comparing discrimination and reclassification.
Results During a mean follow-up of 3.7 years (max.
7.0 years), 1,148 CVD events (cases) were identified. Addi-
tion of pulmonary, mediastinal and pleural features to a car-
diovascular imaging findings-based prediction model led to
marginal improvement of discrimination (increase in c-index
from 0.72 (95 % CI 0.71–0.74) to 0.74 (95 % CI 0.72–0.75))
and reclassification measures (net reclassification index 6.5 %
(p<0.01)).
Conclusion Pulmonary, mediastinal and pleural features have
limited predictive value in the identification of subjects at high
risk of CVD events beyond cardiovascular findings on diag-
nostic chest CT scans.
Key Points
• Incidental cardiovascular findings on routine chest CT can
predict cardiovascular disease
• Non-cardiovascular chest CT abnormalities are associated
with cardiovascular disease
• Non-cardiovascular chest CT features have limited predic-
tive value beyond cardiovascular features
Keywords Chest CT imaging . CVD risk prediction .
Pulmonary disease-related CT findings . Cardiovascular
imaging . Cardiovascular disease
Introduction
Chest computed tomography (CT) has emerged as a common-
ly used imaging modality in the evaluation of thoracic dis-
eases, with more than 10 million chest CTs performed annu-
ally in the USA [1, 2]. In addition to the clinically valuable
information embedded in the imaging findings related to the
chest CT indication, incidental findings that are unsuspected
or unrelated to the indication contain prognostically valuable
information about multiple diseases [3–5]. In fact, in the case
of incidental cardiovascular CT features, such as coronary and
extracoronary calcifications, cardiovascular disease (CVD)
risk can immediately be derived from these markers of organ
damage visible on CT [6–11].
An explorative study [12] has proposed a different ap-
proach for CVD risk prediction strictly based on information
readily available to the radiologist. The provided prediction
rule allows one to calculate up to 5-year predicted probabili-
ties for non-fatal and fatal CVD events by combining age,
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gender, CT indication, cardiac diameter, left anterior descend-
ing coronary artery calcifications, mitral valve calcifications
and descending aorta calcifications. Addressing conventional
risk factors is not possible in daily routine practice, since this
information is in general not available to the radiologist.
Moreover, risk factor detection, earlier in the disease process,
precedes in many patients the presence of the image findings.
Additionally, a substantial proportion of CVD events occur in
individuals without conventional risk factors or in subjects
with yet undetected or underdiagnosed risk factors [13]. There
are several studies supporting a shift in CVD risk assessment
from conventional risk factors, as they are merely a surrogate
for atherosclerosis, to direct measures of subclinical athero-
sclerosis [13–15]. Utilization of markers of subclinical target
organ damage for CVD risk prediction, like cardiovascular CT
features incorporated in the imaging-based model, provide a
novel strategy and adequate estimation of CVD risk irrespec-
tive of the conventional risk factor status.
Emerging data indicate a direct link between certain pul-
monary diseases and cardiovascular disease. Mechanisms
such as ongoing pulmonary inflammation, repair mechanisms,
misbalances between proteases and anti-proteases and auto-
immune phenomena have been suggested to explain the rela-
tionship between pulmonary diseases and cardiovascular dis-
ease. Additionally, chest CT abnormalities reflecting these
pulmonary diseases, e.g. airway thickening, pulmonary
ground glass opacity, pulmonary consolidation, pleural effu-
sion and mediastinal lymphadenopathy, were found to be
associated with CVD [16–19]. Whether these pulmonary,
mediastinal and pleural characteristics, which can be evaluat-
ed in the same image as the cardiovascular findings without
additional examining or radiation exposure, improve CVD
risk estimation beyond what is possible with cardiovascular
findings is unknown. To address this issue we evaluated the
incremental predictive value of pulmonary, mediastinal and
pleural findings on routine diagnostic chest CT over a cardio-
vascular CT features-based prediction model.
Materials and methods
Study population
This is an ancillary study of the PROgnostic Value of
unrequested Information in Diagnostic Imaging (PROVIDI)
study. The PROVIDI study was conceived from the perspec-
tive of the radiologists, to determine the prognostic relevance
of the growing amount of uncertain incidental findings. Only
information readily available to the radiologist is addressed in
this study. Since in general, other risk factors besides age and
gender are not easy accessible for the radiologist, we could not
provide information on the distribution of these other risk
factors in the current study. This study was approved by the
ethical review board of the University Medical Center Utrecht
(number 06/193); informed consent was waived because a
privacy protocol was implemented in the study protocol.
The rationale and design of the PROVIDI study has been
described in detail [4]. Briefly, the study population comprised
23,443 subjects aged 40 years and over who underwent rou-
tine clinical chest CT imaging between 2002 and 2005 for
various diagnostic clinical indications in participating hospi-
tals in the Netherlands. Patients with a diagnosis of primary
lung cancer (including mesothelioma) or distant metastatic
disease from other types of cancer (excluding hematologic
malignancies) at baseline were excluded (n=9,077), because
of the poor prognosis. Also excluded were patients yielding
prior history of CVD or subjects with a CT referral indication
directly related to (suspected) cardiovascular pathology (n=
2,303), to ensure that the evaluated calcifications were truly
Bincidental^.
Sample selection and study design
In the present study, 10,410 participants represent the full
study cohort and were considered for analyses. Subjects who
developed a CVD event during follow-up were identified as
cases. We used a case-cohort approach as introduced by
Prentice [20], using all cases and an approximately 10 %
random sample from the full study cohort (subcohort) at the
beginning of the study. With sampling fractions of at least
0.10, results of a case-cohort analysis are similar to the full
study cohort analysis [21]. The cases together with the
subcohort define the study population in which the imaging
characteristics are determined. The advantage of this design is
that it enables survival analyses without the need to score the
chest CT images from the full study cohort. Figure 1 shows a
flowchart of the study design and the selection of cases and
subcohort.
Scoring of CT characteristics
All chest CT examinations were obtained between January
2002 and December 2005, using multi-detector CT (2–64
detector rows) from different vendors according to the pre-
vailing routine clinical protocols of the participating hospitals.
All types of CT (including non-contrast and non-triggered)
protocols were considered eligible as long as the field of view
included the heart and full length of the thoracic aorta.
Section thicknesses varied according to the chest CT indica-
tion and corresponding protocol.
CT examinations were examined for left anterior descend-
ing (LAD) coronary artery calcifications, mitral valve calcifi-
cations, descending aorta calcifications and cardiac diameter.
This set of four cardiovascular CT features enabled adequate
identification of subjects at high risk of CVD [12]. Addition-
ally, CT images were evaluated for airway thickening, ground
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glass, consolidation, pleural effusion and mediastinal lymph
node diameter. These five pulmonary disease-related CT find-
ings have been previously shown to be associated with future
CVD events [19]. The presence and extent of the cardiovas-
cular and pulmonary CT abnormalities were graded using a
validated simple ordinal [22] (Table 1). Extensive information
about the definitions and grading of the CT features can be
found in the Electronic Supplementary Material and examples
in Fig. 2.
Follow-up and cardiovascular events
CVD events were defined as all coronary events (myocardial
infarction, coronary death, coronary insufficiency and angi-
na), cerebrovascular events (ischaemic stroke, haemorrhagic
stroke and transient ischaemic attack), peripheral artery dis-
ease (intermittent claudication) and heart failure. Data on fatal
and non-fatal CVD events were obtained from the Dutch
National Registry of Hospital Discharge Diagnoses and the
National Death Registry. This registry assigns a code to each
non-fatal and fatal CVD event, according to the International
Classification of Diseases, 9th and10th Revision (ICD-9 and
ICD-10); details are shown in the Electronic Supplementary
Material. The database was linked to the study cohort with a
validated probabilistic method [23, 24]. As previously dem-
onstrated, the overall quality of Dutch national registers is
high and ICD codes have high sensitivities and positive pre-
dictive values [25, 26], enabling reliable identification of cases
and follow-up. Whenever multiple events occurred, the first
event was taken as an end point.
Statistical analyses
Baseline characteristics and chest CT findings were sum-
marized for the subcohort and the cases. Quantitative data
were described with median (interquartile range) because
of their abnormal distribution. Qualitative data were de-
scribed using percentages. To compare subjects within the
subcohort and patients who experienced a CVD event,
differences in continuous variables were analysed with
Mann–Whitney U test. Differences in categorical variables
were tested using chi-square tests. The analysis comprised
three stages. The first was an assessment of the associa-
tions between each pulmonary disease-related CT finding
and future CVD events; the second involved the derivation
of a cardiopulmonary CT features prediction rule
consisting of the four graded cardiovascular CT features,
plus a selection of pulmonary disease-related CT findings
(a forward stepwise procedure was used for predictor se-
lection) and the third involved comparison of discrimina-
tion and reclassification between the cardiopulmonary CT
features model and the model only based on cardiovascular
CT features. For a more detailed statistical description, see
the Electronic Supplementary Material. Analyses were
performed with R-project software package, version 2.15
(www.r-project.org).
Fig. 1 Flowchart of study design. CBS Central Bureau of Statistics, LMR Dutch medical data registration
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Table 1 Semi-quantitative grading score of various cardiovascular and pulmonary disease-related CT findings on chest CT
0=Absent 1=Mild 2=Moderate 3=Severe
LAD coronary artery calcifications
Number and size of calcifications None 1–2 focal limited
to ≤2 slices






Number and size of calcifications None ≤3 focal 4–5 focal or 1 extending
≥3 slices
>5 focal or >1 extending
≥3 slices
Mitral valve calcifications
Number of affected valve leaflet(s) None 1 leaflet 2 leaflets
Airway thickening
Number of affected lobes (range 0–5) 0 1 2 ≥3
Consolidation
Number of affected lobes (range 0–5) 0 1 2 ≥3
Ground glass
Number of affected lobes (range 0–5) 0 1 2 ≥3
Pleural effusion
Sum of left and right fluid layers thickness on
axial images, cm
0 <6 6–12 >12
Lymph node
Short axis diameter of the largest lymph node, mm <6 6–10 >10
LAD left anterior descending
Fig. 2 Examples of pulmonary,
mediastinal and pleural CT
imaging characteristics. a Airway
thickening (white arrow) and
ground glass in the left lower lobe
(black arrows). b Consolidation
in the right under lobe (black
arrow). c Short axis diameter
measurement of the largest
mediastinal lymph node. d
Pleural effusion measurement of
left-sided fluid layer on axial
image
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Results
During a median follow-up of 3.7 years (range 3.2–7.0 years),
1,148 CVD events occurred among the 10,410 subjects of the
baseline cohort. Table 2 presents the baseline characteristics
and chest CT imaging findings for the subcohort and CVD
cases. As expected, the cases were slightly older, more often
male and had more numerous and more severe cardiovascular
calcifications as well as pulmonary, mediastinal and pleural
abnormalities compared to the subcohort. These differences
were all statistically significant (p<0.05).
In Table 3, unadjusted and adjusted hazard ratios (HRs) and
their 95 % confidence intervals (CIs) for CVD events are
presented for the mild, moderate and severe categories of
airway thickening, ground glass, consolidation, pleural effu-
sion as well as lymph node diameter compared with the absent
category. All five pulmonary, mediastinal and pleural findings
were significantly related to CVD risk in the age- and sex-
adjusted analysis. When estimates were fully adjusted for age,
gender, CT indication, LAD coronary artery calcifications,
mitral valve calcifications and descending aorta calcifications
and cardiac diameter, the association between airway thicken-
ing and consolidations with CVD events was no longer sig-
nificant. Pulmonary, mediastinal and pleural findings that
were independently related to future CVD events after ac-
counting for the predictors included in the cardiovascular CT
features-based model were ground glass, pleural effusion and
lymph node diameter. The HRs for comparison of the severe
versus the absent category for these CT features were as
follows: ground glass, HR 2.0 (95 % CI 1.6–2.4); pleural
effusion, HR 1.7 (95 % CI 1.3–2.2) and lymph node diameter,
HR 1.5 (95 % CI 1.3–1.8) (Fig. 3).
To assess the incremental value of pulmonary disease-
related CT features over cardiovascular imaging findings, first
a Cox proportional hazard model including limited patient
characteristics and cardiovascular CT findings was
prespecified. This model will further be referred to as the
Bcardiovascular CT features model^ and comprised the fol-
lowing predictors: age, gender, CT indication, cardiac diame-
ter, LAD coronary artery calcifications, mitral valve calcifica-
tions and descending aorta calcifications. Second, a
Bcardiopulmonary CT features model^ was derived, adding
the three strongest and independent predictors by Cox propor-
tional hazard models of single pulmonary disease-related CT
features with future CVD events (ground glass, pleural effu-
sion and lymphadenopathy) to the cardiovascular CT features
model. The same selection of the best predictors was obtained
with the use of a forward stepwise procedure, for details see
the Electronic Supplementary Material.
Addition of ground glass, pleural effusion and lymph node
diameter to the cardiovascular CT features model led to mar-
ginal improvement of discrimination and reclassification mea-
sures (Table 4). Discrimination, expressed by the c-index,
increased from 0.72 (95 % CI 0.71–0.74) to 0.74 (95 % CI
0.72–0.75). Reclassification as measured by the net
Table 2 Baseline characteristics and chest CT imaging findings for




Age, years 61 (52–71) 68 (59–75)
Male gender, n (%) 698 (58) 723 (63)
CT indication, n (%)
Pulmonary disease 457 (38) 505 (44)
Haematological malignancy 132 (11) 80 (7)
Mediastinal disease 132 (11) 103 (9)
Rules out lung cancer 277 (23) 241 (21)
Pulmonary embolism 72 (6) 80 (7)
Other 144 (12) 126 (11)
LAD coronary artery calcifications, n (%)
Mild 373 (31) 298 (26)
Moderate 229 (19) 321 (28)
Severe 120 (10) 207 (18)
Descending aorta calcifications, n (%)
Mild 325 (27) 333 (29)
Moderate 180 (15) 253 (22)
Severe 72 (6) 195 (17)
Mitral valve calcification, n (%)
1 leaflet 84 (7) 149 (13)
2 leaflets 12 (1) 34 (3)
Cardiac diameter, mm 125 (115–134) 130 (121–141)
Airway thickening, n (%)
Mild 120 (10) 138 (12)
Moderate 132 (11) 161 (14)
Severe 108 (9) 138 (12)
Ground glass, n (%)
Mild 144 (12) 172 (15)
Moderate 84 (7) 149 (13)
Severe 96 (8) 138 (12)
Consolidation, n (%)
Mild 180 (15) 184 (16)
Moderate 108 (9) 126 (11)
Severe 48 (4) 57 (5)
Pleural effusion, n (%)
Mild 60 (5) 57 (5)
Moderate 72 (6) 115 (10)
Severe 48 (4) 92 (8)
Lymph node diameter, n (%)
6–10 mm 457 (38) 551 (48)
>10 mm 252 (21) 287 (25)
Values are mean±standard deviation, median (interquartile range) or n
(%)
LAD left anterior descending
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reclassification improvement (NRI) was 6.5 % (P<0.01). This
indicates that with the cardiopulmonary CT features model
6.5 % of the subjects are more appropriately reclassified
compared with the cardiovascular CT features model, with
0 % improvement in cases and 6.5 % in noncases.
Discussion
In this case-cohort study of 10,410 subjects who
underwent routine clinical chest CT scanning, the incre-
mental value of pulmonary, mediastinal and pleural find-
ings over certain cardiovascular characteristics in CVD
event risk prediction was evaluated. Ground glass, pleural
effusion and lymphadenopathy were associated with an
increased risk of CVD events, independent of age, gender,
CT indication, cardiac diameter, LAD coronary artery
calcifications, mitral valve calcifications and descending
aorta calcifications. However, improvement of CVD event
risk prediction beyond cardiovascular imaging findings
with addition of these three pulmonary, mediastinal and
pleural imaging features was only marginal. Thus, inciden-
tal vascular calcifications alone offer an important oppor-
tunity to identify patients at high risk of cardiovascular
disease. Therefore we recommend to routinely report these
findings to allow further work-up and/or preventative treat-
ment. This can be an efficient strategy to effectuate a
further decline of the global cardiovascular disease burden
without providing additional radiation to the patient or
increasing health-care costs. However, in many institutions,
there still is a controversy among radiologists whether
incidental findings should be reported. Correspondingly, a
professional consensus about standardized and universal
reporting of incidental vascular calcification in routine
radiological practice should be discussed and further
developed.
Our data provide evidence for the established direct asso-
ciation between certain pulmonary diseases and CVD
[16–19], as airway thickening, ground glass, consolidation,
pleural effusion and lymphadenopathy were demonstrated to
be associated with CVD risk. This positive relation can be
explained because an important mutual cause for these imag-
ing findings, inflammation, has a central role in the athero-
sclerotic process precipitating CVD events [27–30]. Consis-
tent with our findings, markers of inflammation measurable in
serum or plasma (e.g. high sensitivity C-reactive protein,
interleukin 6, fibrinogen) have also been associated with
CVD risk [31]. Additionally, some abnormalities reflect
(subclinical) heart failure. The most common cause of bilat-
eral pleural effusion is heart failure [27]. Bilateral effusion can
be a direct marker of CVD, explaining the significant associ-
ation between pleural effusion and CVD risk even after ad-
justment for cardiovascular imaging features.
When adjusted for cardiovascular imaging features, only
ground glass, pleural effusion and lymphadenopathy were
demonstrated to be independently associated with CVD event
risk. This may indicate that these pulmonary disease-related
CT findings exert their hazardous effect on future CVD events
through other pathways than those through which cardiovas-
cular findings affect CVD risk. However, as these abnormal-
ities may reflect (subclinical) heart failure it could well be that
they are merely a consequence of the disease. Ground glass,
pleural effusion and lymphadenopathy were selected for ad-
dition to the cardiovascular CT features model as they were
independently associated with CVD. Using a forward step-
wise procedure resulted in identical predictor selection. Al-
though these features were independently associated with the
risk of later CVD events, their incremental value beyond
cardiovascular findings was marginal. Addition of these three
imaging features to the cardiovascular CT features model
Table 3 Hazard ratios (95 % CI) for cardiovascular events (n=1,148)
during a median follow-up period time of 3.7 years according to the
pulmonary disease-related CT findings on routine chest CT
Sex- and age-adjusted
HR (95 % CI)
Multivariablea adjusted
HR (95 % CI)
Airway thickening (%)
Absent Reference Reference
Mild 1.3 (1.3–1.5) 1.0 (0.8–1.3)
Moderate 1.3 (1.1–1.5) 1.2 (1.0–1.4)
Severe 1.4 (1.1–1.7) 1.1 (0.9–1.3)
Consolidation (%)
Absent Reference Reference
Mild 1.1 (0.9–1.3) 0.9 (0.7–1.1)
Moderate 1.5 (1.2–1.8) 1.2 (1.0–1.5)
Severe 1.5 (1.1–1.9) 1.3 (1.0–1.7)
Ground glass (%)
Absent Reference Reference
Mild 1.4 (1.2–1.7) 1.6 (1.3–1.8)
Moderate 1.9 (1.4–2.6) 2.0 (1.7–2.4)
Severe 2.2 (1.6–3.0) 2.0 (1.6–2.4)
Pleural effusion (%)
Absent Reference Reference
Mild 1.3 (1.0–1.7) 1.0 (0.8–1.3)
Moderate 2.7 (1.8–4.0) 1.7 (1.4–2.2)
Severe 2.3 (1.5–3.5) 1.7 (1.3–2.2)
Lymph node diameter (mm)
<6 Reference Reference
6–10 1.8 (1.5–2.0) 1.5 (1.3–1.8)
>10 1.9 (1.6–2.2) 1.5 (1.3–1.8)
a Multivariable adjusted = adjustment for predictors of the cardiovascular
CT features model: age, gender, CT indication, left anterior descending
coronary artery calcification, mitral valve calcification, descending aortic
calcification and the cardiac diameter
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yielded an NRI in the intermediate-risk group of less than
10 %, falling below reclassification thresholds that are con-
sidered clinically relevant [32].
Limitations
One of the limitations of our study that merits consideration is
that our cohort was comprised of a population of Caucasian
Dutch descent. Therefore the generalizability of our findings
to populations of different racial or ethnic backgrounds re-
mains uncertain. Another issue that merits consideration is
that assessment of pulmonary CT findings like consolidations,
ground glass and airway thickening had a relatively low inter-
reader reliability. This may have influenced the association
between these findings with CVD events. Moreover, we
favoured not to use expert cardiothoracic radiologists as in
our practice most chest CT images are interpreted by
general radiologists, and often the lungs are read by cardiac
radiologists and the arteries by chest radiologists. We think
that the quality of the readers will have minimally affected
the results. Additionally, the CT examinations varied in
slice thickness, use of contrast medium and CT machine
vendors. This may have given rise to the possibility of
missing subtle CT findings like small coronary artery cal-
cification, bronchial wall thickening and ground glass
opacity. However, our visual assessment of the CT findings
is a real practice scenario, where visual assessment based
on a variety of protocols, also compared to quantitative
assessment, has been demonstrated to be relatively simple,
inexpensive and independent of machine and reconstruc-
tion algorithms [33]. Lastly, in prognostic research, candi-
date predictors should be measured using methods easily
applicable—or potentially applicable—to daily practice
[34].
Table 4 Discrimination and reclassification estimates for cardiovascular events (n=1,148 events) during a median follow-up period time of 3.7 years
according to the cardiovascular CT features model without and with addition of pulmonary, mediastinal and pleural chest CT findings
Cardiovascular CT features modelc Cardiopulmonary CT features modeld
C-statistic (95 % CI)a 0.72 (0.71–0.74) 0.74 (0.72–0.75)
Net Reclassification Index (NRI) (95 % CI)b NA 6.50 (4.44–8.55)
a C-statistic is corrected for over optimism by using 150 bootstrap repetitions
b Percentage of NRI (95 % CI) for the cardiovascular CT features model versus the cardiopulmonary CT features model, using 5-year predicted
cardiovascular risks and risk categories of <5 %, 5–10 % and >10 %
c Cardiovascular CT features model included the following variables: age, gender, CT indication, left anterior descending coronary artery calcification,
mitral valve calcification, descending aortic calcification and the cardiac diameter
d Cardiopulmonary CT features model included the following variables: age, gender, CT indication, left anterior descending coronary artery
calcification, mitral valve calcification, descending aortic calcification and the cardiac diameter plus ground glass, pleural effusion and lymph node
diameter
Fig. 3 Multivariable-adjusted hazard ratios (HRs) and 95 % confidence
interval (95 % CI) for cardiovascular events comparing the severe versus
the absent category of pleural effusion (HR 1.7 [95%CI 1.3–2.2]), lymph
node diameter (HR 1.5 [95 % CI 1.3–1.8]), airway thickening (HR 1.1
[95 % CI 0.9–1.3]), consolidation (HR 1.3 [95 % CI 1.0–1.7] and ground
glass (HR 2.0 [95 % CI 1.6–2.4])
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Conclusion
Ground glass, pleural effusion and lymphadenopathy on rou-
tine clinical CT examinations were independent predictors of
future CVD events. However, addition of these imaging fea-
tures to a risk model based on cardiovascular findings only
marginally improves 5-year CVD event risk prediction in a
Caucasian Dutch population. Pulmonary, mediastinal and
pleural features have limited predictive value in the identifi-
cation of subjects at high risk of CVD events beyond cardio-
vascular findings on diagnostic chest CTs.
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